Andrew Lloyd Webber on volunteering for Covid vaccine trial to do "anything to get theatres open again"
Andrew Lloyd Webber appeared on Good Morning Brtiain today to discuss his involvement with the Oxford Covid-19 vaccine trial and how he will do "anything to get theatres open again".
The 72-year-old told Piers Morgan and Susanna Reid that when he heard they needed older people for the trial he volunteered straight away and has had almost "no effects from it at all".
Speaking about what being involved with the trial is like he said: "It's very carefully monitored, you do comprehensive blood tests and I fill in a daily online form to say if I have any kind of symptoms. I guess all that information is collated.
"There are two vaccines and they don't tell you which one you have had. I probably shouldn't say anymore because you are supposed to keep it under wraps."
The trial was closed down for a few days when one participant fell ill.
Andrew explained what happened during that time and when it restarted: "I was supposed to go up to Oxford on the Thursday and I got a call on Wednesday night saying don't come. Then I got a call on Saturday saying could I come on Sunday.
"When I went up there on Sunday the atmosphere in there was rather like a first night. It was totally electric, the nurses excited, loads of people coming in like myself. It's a very interesting thing to be a part of."
After getting the vaccine, the composer wrote: 'I’ll do anything to get theatres large and small open again and actors and musicians back to work'
The day before Lloyd Webber explained on social media why he was taking part in the trials. "I am excited that tomorrow I am going to be vaccinated for the Oxford Covid 19 trial. I'll do anything to prove that theatres can re-open safely.'
The University of Oxford and the drug company AstraZeneca are working on the development of the experimental vaccine called ChAdOx1 nCoV-19.
Thousands of people in the UK, United States, Brazil and South Africa have volunteered to take part in clinical trials
As recently as 20 July , researchers announced the initial results of 1,077 people were promising, suggesting that the vaccine is both safe and triggers an immune response, according to the BBC.
The next step in the study involves expanding the trial at a higher dose to thousands more people, which is where Webber appeared to come into the play.